Disease Markers / 2013 / Article / Fig 1

Clinical Study

Interleukin 18 as a Marker of Chronic Nephropathy in Children after Anticancer Treatment

Figure 1

(a) Concentrations of beta-2 microglobulin depending on treatment modality. (b) Concentrations of beta-2 microglobulin depending on clinical evidence of nephrotoxicity. (c) Concentrations of IL-18 depending on treatment modality. (d) Concentrations of IL-18 depending on clinical evidence of nephrotoxicity.
369784.fig.001a
(a)
369784.fig.001b
(b)
369784.fig.001c
(c)
369784.fig.001d
(d)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.